{"id":35374,"date":"2024-12-13T10:22:14","date_gmt":"2024-12-13T09:22:14","guid":{"rendered":"https:\/\/www.pkf-attest.es\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/"},"modified":"2026-09-15T09:57:15","modified_gmt":"2026-09-15T07:57:15","slug":"informe-iberian-ma-sector-farmaceutico-2","status":"publish","type":"noticias","link":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/","title":{"rendered":"Iberian M&A Overview – Pharmaceutical Industry"},"content":{"rendered":"\n

Strategic investors at the forefront of operations in the global pharmaceutical sector<\/h2>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n

In the global healthcare sector, strategic investors are positioned at the forefront of deal activity, with a clear focus on acquiring both capacity and innovation. During the first half of 2024, a slight decrease in global mergers and acquisitions (M&A) activity was observed compared to the second half of 2023. This behavior reflects a cautious M&A environment, with investors preferring to wait for potential interest rate cuts before committing to significant transactions.<\/p>\n\n\n\n

Despite this caution, EBITDA trading multiples increased compared to the previous half-year, driven by relevant industry trends. This phenomenon highlights the resilience of the sector and its ability to adapt to macroeconomic challenges.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
\n

Discover the global mergers and acquisitions activity in the healthcare<\/strong> of the healthcare sector in Iberia<\/strong><\/h3>\n\n\n\n
<\/div>\n\n\n\n

Download our exclusive and free report “Iberian M&A Overview”, prepared by the M&A experts at PKF Attest.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Access essential market data and trends in 2024.<\/p>\n<\/div><\/div>\n\n\n\n

\n
\"m&A<\/figure>\n<\/div>\n\n\n
\n
Download report<\/a><\/div>\n<\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

Dynamics in the Iberian region<\/strong><\/h2>\n\n\n\n


In the Iberian pharmaceutical sector, there was significant activity on the part of private equity funds. One of the most significant transactions in fiscal 2024 was the acquisition of a minority stake in Grifols by Flat Footed, a US investment management firm. This deal, valued at approximately 111 million euros, underlines the continued attractiveness of healthcare assets in the region for international investors.<\/p>\n\n\n\n

In terms of EV\/EBITDA valuation multiples, the healthcare sector averaged 12x, while the veterinary sector stood at 10.5x for fiscal 2024, reflecting differences in market dynamics and growth expectations within the two segments.<\/p>\n\n\n\n

Download the Iberian M&A Overview on the pharmaceutical sector.<\/p>\n\n\n\n

Contact an expert in Mergers & Acquisitions services<\/a><\/p>\n","protected":false},"featured_media":12612,"template":"noticias-corporativa-single-post.php","categories":[],"tags":[246,225,215],"novedades_corporativa":[],"class_list":["post-35374","noticias","type-noticias","status-publish","has-post-thumbnail","tag-adquisicion-en","tag-ma-en","tag-report","entry"],"acf":[],"yoast_head":"\nIberian M&A Overview - Pharmaceutical Industry - PKF Attest<\/title>\n<meta name=\"description\" content=\"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iberian M&A Overview - Pharmaceutical Industry\" \/>\n<meta property=\"og:description\" content=\"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/\" \/>\n<meta property=\"og:site_name\" content=\"PKF Attest\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-15T07:57:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/\",\"url\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/\",\"name\":\"Iberian M&A Overview - Pharmaceutical Industry - PKF Attest\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pkf-attest.es\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/man-working-as-pharmacist-min-scaled.jpg\",\"datePublished\":\"2024-12-13T09:22:14+00:00\",\"dateModified\":\"2026-09-15T07:57:15+00:00\",\"description\":\"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pkf-attest.es\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/man-working-as-pharmacist-min-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pkf-attest.es\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/man-working-as-pharmacist-min-scaled.jpg\",\"width\":2560,\"height\":960,\"caption\":\"M&A overview\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/noticias\\\/informe-iberian-ma-sector-farmaceutico-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iberian M&A Overview – Pharmaceutical Industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/\",\"name\":\"PKF Attest\",\"description\":\"PKF Attest\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#organization\",\"name\":\"PKF-Attest\",\"url\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pkf-attest.es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Logotipo_PKF-Attest-675x675-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pkf-attest.es\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Logotipo_PKF-Attest-675x675-1.jpg\",\"width\":675,\"height\":675,\"caption\":\"PKF-Attest\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pkf-attest.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/1078028\\\/admin\\\/dashboard\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Iberian M&A Overview - Pharmaceutical Industry - PKF Attest","description":"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/","og_locale":"en_US","og_type":"article","og_title":"Iberian M&A Overview - Pharmaceutical Industry","og_description":"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.","og_url":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/","og_site_name":"PKF Attest","article_modified_time":"2026-09-15T07:57:15+00:00","og_image":[{"width":2560,"height":960,"url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/","url":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/","name":"Iberian M&A Overview - Pharmaceutical Industry - PKF Attest","isPartOf":{"@id":"https:\/\/www.pkf-attest.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/#primaryimage"},"image":{"@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","datePublished":"2024-12-13T09:22:14+00:00","dateModified":"2026-09-15T07:57:15+00:00","description":"Download the full report. Strategic investors lead the global healthcare sector in a cautious environment in 2024. Private Equity stands out.","breadcrumb":{"@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/#primaryimage","url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","contentUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2024\/12\/man-working-as-pharmacist-min-scaled.jpg","width":2560,"height":960,"caption":"M&A overview"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pkf-attest.es\/en\/noticias\/informe-iberian-ma-sector-farmaceutico-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pkf-attest.es\/en\/"},{"@type":"ListItem","position":2,"name":"Iberian M&A Overview – Pharmaceutical Industry"}]},{"@type":"WebSite","@id":"https:\/\/www.pkf-attest.es\/en\/#website","url":"https:\/\/www.pkf-attest.es\/en\/","name":"PKF Attest","description":"PKF Attest","publisher":{"@id":"https:\/\/www.pkf-attest.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pkf-attest.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pkf-attest.es\/en\/#organization","name":"PKF-Attest","url":"https:\/\/www.pkf-attest.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pkf-attest.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg","contentUrl":"https:\/\/www.pkf-attest.es\/wp-content\/uploads\/2023\/12\/Logotipo_PKF-Attest-675x675-1.jpg","width":675,"height":675,"caption":"PKF-Attest"},"image":{"@id":"https:\/\/www.pkf-attest.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/1078028\/admin\/dashboard\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/noticias\/35374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/media\/12612"}],"wp:attachment":[{"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/media?parent=35374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/categories?post=35374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/tags?post=35374"},{"taxonomy":"novedades_corporativa","embeddable":true,"href":"https:\/\/www.pkf-attest.es\/en\/wp-json\/wp\/v2\/novedades_corporativa?post=35374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}